StreetInsider.com News Articles

Form 6-K IMMUTEP Ltd For: Jul 13

Tue, 14 Jul 2026 06:02:00 -0400

si-local-file:///var/storage/secattach/20260714/26764188.html

Form 6-K IMMUTEP Ltd For: Jul 13

Tue, 14 Jul 2026 06:02:00 -0400

si-local-file:///var/storage/secattach/20260714/26764188.html

Form 6-K IMMUTEP Ltd For: Jul 13

Tue, 14 Jul 2026 06:02:00 -0400

si-local-file:///var/storage/secattach/20260714/26764188.html

Immutep Limited (IMMP) Reiterated at Market Perform by Citizens on Phase 1 Data

Tue, 14 Jul 2026 04:12:03 -0400

Citizens analyst Reni Benjamin reiterated a Market Perform rating on Immutep Limited (NASDAQ: IMMP).

The analyst commented, "We maintain our Market Perform rating for Immutep, based on a cash per share analysis. Yesterday, Immutep reported updated data from an investigator-initiated Phase 1 study showcasing an impressive mOS of 30.9 months in 51 1L NSCLC patients. We view these data as promising, and yet another piece of evidence that the Phase 3 TACTI-004 futility analysis failure is likely due to some other issue rather than biologic. With the root cause analysis of the TACTI-004 trial underway, meaningful progress on IMP761 in AID,

Form 6-K IMMUTEP Ltd For: Jun 04

Fri, 05 Jun 2026 06:02:00 -0400

si-local-file:///var/storage/secattach/20260605/26607940.html

Form 6-K IMMUTEP Ltd For: Jun 04

Fri, 05 Jun 2026 06:02:00 -0400

si-local-file:///var/storage/secattach/20260605/26607940.html

Form 6-K IMMUTEP Ltd For: Jun 04

Fri, 05 Jun 2026 06:02:00 -0400

si-local-file:///var/storage/secattach/20260605/26607940.html

SueWallSt Reminds Immutep Limited Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of July 6, 2026 - IMMP

Thu, 28 May 2026 09:00:00 -0400

Notice to Pension Funds, Asset Managers, and Fiduciaries Holding IMMP: An 83% Single-Day Loss in Immutep ADRs Raises Urgent Questions About Portfolio Exposure and Fiduciary Recovery Obligations

NEW YORK, May 28, 2026 /PRNewswire/ -- Institutional investors holding positions in Immutep Limited (NASDAQ: IMMP) during the period from March 24, 2025 through March 12, 2026 may wish to evaluate lead plaintiff opportunities in a pending securities class action. Request an institutional investor loss assessment. You may also contact Joseph E. Levi, Esq. at jlevi@SueWallSt.com or (888) SueWallSt.

SueWallSt Reminds Immutep Limited Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of July 6, 2026 - IMMP

Thu, 28 May 2026 09:00:00 -0400

Notice to Pension Funds, Asset Managers, and Fiduciaries Holding IMMP: An 83% Single-Day Loss in Immutep ADRs Raises Urgent Questions About Portfolio Exposure and Fiduciary Recovery Obligations

SueWallSt Reminds Immutep Limited Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of July 6, 2026 - IMMP

Thu, 28 May 2026 09:00:00 -0400

Notice to Pension Funds, Asset Managers, and Fiduciaries Holding IMMP: An 83% Single-Day Loss in Immutep ADRs Raises Urgent Questions About Portfolio Exposure and Fiduciary Recovery Obligations

SueWallSt Reminds Immutep Limited Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of July 6, 2026 - IMMP

Thu, 28 May 2026 09:00:00 -0400

Notice to Pension Funds, Asset Managers, and Fiduciaries Holding IMMP: An 83% Single-Day Loss in Immutep ADRs Raises Urgent Questions About Portfolio Exposure and Fiduciary Recovery Obligations

SueWallSt Reminds Immutep Limited Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of July 6, 2026 - IMMP

Thu, 28 May 2026 09:00:00 -0400

Notice to Pension Funds, Asset Managers, and Fiduciaries Holding IMMP: An 83% Single-Day Loss in Immutep ADRs Raises Urgent Questions About Portfolio Exposure and Fiduciary Recovery Obligations

SueWallSt Reminds Immutep Limited Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of July 6, 2026 - IMMP

Thu, 28 May 2026 09:00:00 -0400

Notice to Pension Funds, Asset Managers, and Fiduciaries Holding IMMP: An 83% Single-Day Loss in Immutep ADRs Raises Urgent Questions About Portfolio Exposure and Fiduciary Recovery Obligations

Immutep Quarterly Activities Report Q3 FY26